Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-044649

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Isaac E. Ciechanover
Officer — Chief Executive Officer · Director
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 15, 2015M31,508$0.00A69,508D
Common StockMay 15, 2015F14,801$37.30D54,707D
Common StockF2holding———392,300ISee footnote
Common StockF3holding———488,653ISee footnote
Common StockF4holding———180,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F6,F7—May 15, 2015M31,508D——Common Stock31,50863,015D

Explanation of responses